
Rev Dr Dreisbach responds to philosophical implications of Socrates' death on modern debates about euthanasia, suicide, and medical assistance in dying.

Rev Dr Dreisbach responds to philosophical implications of Socrates' death on modern debates about euthanasia, suicide, and medical assistance in dying.

A Yale study reveals how racial and ethnic factors impact access to opioid use disorder treatment in emergency departments, highlighting barriers and solutions.

A new study reveals how genetics influences leisure, work, and home physical activity, highlighting the unique health benefits of exercise during leisure time.

Kim Smolderen, PhD, pioneers integrated psychological care for heart patients, enhancing mental health support to improve cardiovascular outcomes and patient well-being.

Explore the latest findings on neurotransmitter levels and innovative treatments for major depressive disorder, including TMS and cognitive impacts.

Psychotherapy faces skepticism in psychiatry, yet it remains vital for understanding patients' narratives and enhancing therapeutic relationships.

New analysis qualifies OPTIMUM study, finding antidepressant combinations more effective than switching for treatment resistant depression in elderly.

Explore the intersection of music, psychiatry, and social justice through Shostakovich's powerful compositions and their relevance today.

In this Tales From the Clinic article, explore the hidden struggles of female physicians facing subfertility and burnout, and discover essential strategies for support and intervention.

In this CME article, discover effective strategies for prescribing MAOIs in treating major depressive disorder.

Holocaust survivor stories reveal ongoing psychiatric impacts, resilience, and the importance of community support in overcoming trauma and grief.

Explore how mentorship transforms leadership in psychiatry, enhancing emotional intelligence, resilience, and career satisfaction for future healthcare leaders.

Stay informed on PTSD treatment insights, including complex PTSD recognition, diagnostic nuances, and the link between migraines and trauma.

Ketamine-assisted psychotherapy has transformative potential as a groundbreaking approach to mental health that enhances healing through psychedelic experiences.

Apnimed reveals promising results for AD109, a groundbreaking oral treatment for obstructive sleep apnea.

Social media shapes mental health discourse, but misinformation and self-diagnosis risks arise as non-professionals dominate the conversation.

Effective psychodynamic strategies can help to engage difficult patients in psychotherapy, enhancing treatment outcomes and fostering meaningful therapeutic alliances.

Explore Canada's evolving psychiatric landscape, including innovative treatments and the ethical debate surrounding aid in dying for mental illness.


Discover 6 essential steps for psychiatrists to enhance the effectiveness of CBT and DBT in treating young patients.

Positive phase 2 results show that treatment with alixorexton led to statistically significant and dose-dependent improvements in sleep latency among patients with narcolepsy type 1.

BioXcel Therapeutics has submitted an pre-sNDA meeting package for Igalmi's outpatient use, aiming to enhance treatment options for agitation in bipolar disorders and schizophrenia.

Are Americans acting like zombies? How many of us are walking around in a traumatized daze, needing a creative political response?

Women with schizophrenia face increased breast cancer risks linked to long-term prolactin-raising antipsychotic use, highlighting the need for regular screenings and tailored treatment strategies.

The FDA advisory committee votes against brexpiprazole plus sertraline for PTSD, citing insufficient efficacy despite some positive trial results.

The strong emphasis on neuroscience in the 1990s and early 2000s is now giving way to a new psychiatric pluralism, one that increasingly views psychotherapy as real treatment and psychosocial factors as fundamental to understanding the causes and basic nature of psychopathology.

Seaport Therapeutics initiates a pivotal study for GlyphAllo, a potential breakthrough treatment for major depressive disorder, with or without anxious stress.

Social media use among older adults shows potential benefits for reducing loneliness and improving psychosocial well-being, though results vary across studies.

Proposed budget cuts threaten mental health services, risking patient care and community stability while exacerbating existing disparities in access to treatment.

FDA reviewers raise concerns over Rexulti's efficacy for PTSD, highlighting discordant study results ahead of the advisory committee meeting.